This week’s Nas­daq casi­no win­nings: About $700M for 6 biotech IPOs as shares start mov­ing north

We’re look­ing at an­oth­er big round of biotech IPOs for the week. 

My tal­ly of the to­tal haul comes in just shy of $700 mil­lion, fur­ther ev­i­dence that biotech com­pa­nies can still romp and stomp with the in­vest­ment com­mu­ni­ty as the run-up of new of­fer­ings hits 38 for the year to date.

Biotech uni­corn Ru­bius $RU­BY got the bid­ding start­ed, scor­ing $241 mil­lion and a mar­ket cap of $2 bil­lion. Ru­bius’ shares ini­tial­ly spiked, but closed at $24.55 Thurs­day evening af­ter pric­ing at $23 — a mod­est surge. Cri­net­ics $CRNX was close be­hind with $102 mil­lion, but en­joyed the wel­com­ing par­ty on Nas­daq with shares zoom­ing from a $17 ini­tial price up to $22.66 last night.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER